New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
16:05 EDTMYGNMyriad Genetics to acquire Crescendo Bioscience for $270M cash
Myriad Genetics announced that it has entered into a definitive agreement to acquire Crescendo Bioscience for $270M in cash which will be reduced by $25M for the repayment of a loan made to Crescendo and customary adjustments in accordance with the acquisition agreement.
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 29, 2015
07:09 EDTMYGNMyriad Genetics presents myChoice HRD companion diagnostic test data at ASCO
Subscribe for More Information
07:06 EDTMYGNMyriad Genetics presents myRisk Hereditary Cancer data at ASCO
Myriad Genetics announced it will highlight several new clinical studies on its myRisk Hereditary Cancer molecular diagnostic test at the 2015 American Society of Clinical Oncology annual meeting. The myRisk Hereditary Cancer test assesses 25 genes for mutations associated with eight hereditary cancers. Finding deleterious mutations in these genes can help patients with cancer receive appropriate medical care and reduce the risk of second cancers, while patients without cancer can take steps in consultation with their healthcare provider to lower their risk of developing cancer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use